Citius raises ~$15M via registered direct offering of 12.5M shares and warrants

Citius Pharmaceuticals, Inc.

Issued 12.5M shares and warrants to purchase 12.5M shares at $1.20/unit in registered direct offering.
Gross proceeds ~$15M; net proceeds for general corporate purposes, including clinical development.
Warrants have exercise price $1.50, exercisable six months after issuance, expire in five years.
H.C. Wainwright acted as placement agent; cash fee ~$1.05M plus expenses and placement agent warrants.
Offering closed May 8, 2023; 60-day lock-up on further equity issuance and one-year restriction on floating-price securities.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Citius Pharmaceuticals, Inc. entered into Purchase Agreement with certain institutional investors valued at combined offering price of $1.20 (effective 2023-05-03).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional investors
Value: combined offering price of $1.20
Effective: 2023-05-03

Exact text from the filing

On May 3, 2023, Citius Pharmaceuticals, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors for the issuance and sale, in a registered direct offering by the Company (the “Offering”), of 12,500,001 shares of the Company’s common stock, par value $0.001 per share (the “Shares”) and warrants (the “Warrants”) to purchase up to 12,500,001 shares of common stock.

View on SEC.gov

Browse all material agreements →

Citius Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-23-037345

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.